PharmaSentry :: Biotech Advancements Continue to Transform Pharma Industry

home | need help? | feedback | sign out

Article Summary

Biotech Advancements Continue to Transform Pharma Industry
From Market Wire 28-Jun-2010
While the report looks at the entire pipeline to 2015, a key focus of the report is the increasing role of biopharmaceutical products. The growing interest in biotechnology development has transitioned the pharmaceutical industry to biopharmaceuticals in less than a decade. This research report captures these trends, extracting sales for all pharmaceutical and biopharmaceutical products (excluding prophylactic vaccines) and providing estimates and forecasts of the world biopharma market.

Key Concepts
• biopharmaceuticals
• pharmaceuticals
• biotechnology
• growing
• report
• pipeline
• market
• trends
• strategic acquisitions
• partnerships
• flood of new
• management of diseases
• prophylactic vaccines
• extracting sales
• commercialization

Summary

•	For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2691449
•	This research undertaking is the result of a detailed analysis of the late stage R&D pipeline of the 50 top companies in pharmaceuticals, the companies that produce the lion's share of revenues.
•	While the report looks at the entire pipeline to 2015, a key focus of the report is the increasing role of biopharmaceutical products.
•	The growing interest in biotechnology development has transitioned the pharmaceutical industry to biopharmaceuticals in less than a decade.
•	Companies such as Pfizer, Merck and Novartis have been unable to ignore the benefits of investing in biotechnology and have focused on a pipeline in this direction through strategic acquisitions and partnerships with biotech companies and/or through their own in-house research efforts.
•	Companies such as Amgen and Genzyme, which specialize in biotechnology, are now competing with a growing number of companies and the lines between pharmaceutical and biotechnology specialty companies are becoming more blended; which is a trend expected to continue to grow.
•	This research report captures these trends, extracting sales for all pharmaceutical and biopharmaceutical products (excluding prophylactic vaccines) and providing estimates and forecasts of the world biopharma market.
•	The line between pharmaceutical companies and biopharmaceutical companies is blurred to the point of no longer being a distinct.